Showing results (2091-2100 of 2,168) with videos related to

Sort By:
Pageof 217
Blood Cancer Journal|August 1, 2015
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategiesE Padron, G Garcia-Manero, M M Patnaik, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromesSriram Sundaravel, Ryan Duggan, Tushar Bhagat, et al.
Brain, Behavior, and Immunity|April 27, 2020
Baseline immunoreactivity before pregnancy and poly(I:C) dose combine to dictate susceptibility and resilience of offspring to maternal immune activationMyka L Estes, Kathryn Prendergast, Jeremy A MacMahon, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522Minh Tam Truong, Qiang Zhang, David I Rosenthal, et al.
Physical Review Letters|October 20, 2023
Femtosecond Electronic and Hydrogen Structural Dynamics in Ammonia Imaged with Ultrafast Electron DiffractionElio G Champenois, Nanna H List, Matthew Ware, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117Mikkael A Sekeres, Megan Othus, Alan F List, et al.
The Lancet. Haematology|January 15, 2018
Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trialRami Komrokji, Guillermo Garcia-Manero, Lionel Ades, et al.
Blood|July 4, 2012
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsBritta Will, Li Zhou, Thomas O Vogler, et al.
Pageof 217